Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DepoTech issued U.S. patents covering DepoFoam technology

July 22, 1997

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

Syncor to distribute two radiopharmaceuticals from DuPont Merck

July 21, 1997

Genzyme Molecular Oncology and NCI enter drug discovery collaboration

July 21, 1997

GHRH antagonist active in vivo against human renal adenoarcinoma

July 21, 1997

Lung cancer survival improved with new radiotherapy technique

July 21, 1997

Medeva acquires license to anthracycline derivative for the treatment of bladder cancer

July 21, 1997

GeneMedicine receives quarterly payment from Corange in anticancer gene medicine collaboration

July 21, 1997

Novel inhibitors of geranylgeranylation from Baldacci

July 21, 1997

ICN describes antisense oligonucleotides for IL-8 and/or IL-8R

July 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.